You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
李氏大药厂:集团抗病毒药物尤靖安被列入「安徽省应急药品生产企业目录」
阿思达克 02-03 17:52

李氏大药厂(00950.HK)公布,为做好新型冠状病毒感染的疫情防控工作,2020年1月28日国家卫生健康委员会疾病预防控制局指导下、中国疾病预防控制中心编写并在出版的最新《新型冠状病毒感染的肺炎公众防护指南》中,将干扰素列为新型冠状病毒性肺炎防治药物。此外,武汉、上海等地卫健委也先後将干扰素列为治疗药物。

因此,集团抗病毒药物尤靖安(重组人干扰素α2b凝胶)被安徽省经济和信息化厅列入「安徽省应急药品生产企业目录」和「国家工业和信息化部重点物资保障信息监控平台」,成为本次疫情防治的紧急战略物资之一。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account